New business practices drive down pharmaceutical costs
Pharmaceutical companies can stay focused on R&D as they outsource the actual manufacturing to contract manufacturing organizations, which is further enhanced by partnering with specialists capable of controlling operational variabilities in temperature and humidity – leading to improved efficiency and compliance.
Given the cost of developing a new drug and bringing it to market, the high level of R&D expenditures in the pharmaceutical industry are accelerating cost optimization throughout the supply chain.
